The chemical class denoted as FcRn activators encompasses compounds or molecules intricately designed to modulate the activity of the neonatal Fc receptor (FcRn). Positioned as a pivotal component within the immune system, FcRn assumes a critical role in the safeguarding and recycling of immunoglobulin G (IgG) antibodies within the physiological milieu. Ubiquitously present in diverse cell types, including endothelial cells residing in blood vessels and cells comprising the reticuloendothelial system, FcRn's principal function revolves around its interaction with IgG antibodies. This interaction acts as a shield, preventing the premature degradation of IgG within lysosomes and facilitating their orderly return to circulation. Consequently, the intricate orchestration of FcRn's actions extends the half-life of IgG antibodies, a mechanism fundamental to the sustained functionality of the immune system.
Within the realm of scientific inquiry, FcRn activators stand as focal points of exploration for researchers delving into the intricate mechanisms underpinning antibody homeostasis and the orchestration of immune responses. This chemical subclass may encompass a spectrum of entities, ranging from small molecules to compounds strategically designed to augment the binding affinity of FcRn to IgG antibodies or elevate the expression levels of FcRn. Such modulation holds the promise of enhancing the efficiency of antibody recycling processes, unraveling fundamental insights into the dynamic interplay between FcRn and IgG antibodies. The nuanced understanding from the study of FcRn activators thus contributes substantively to the foundational knowledge of immune processes, paving the way for elucidating molecular nuances governing antibody dynamics within the intricate landscape of the immune system.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Given its role in immune modulation, Vitamin D might influence FcRn expression, but direct evidence is limited. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Hormonal changes, especially involving estrogens, might modulate FcRn expression, but the context and specifics need more research. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is often used in in vitro studies to understand glucocorticoid effects on cells, and researched for a variety of conditions ranging from allergic reactions to autoimmune disorders. Given its broad range of cellular impacts, dexamethasone may modulate FcRn expression in certain contexts or cell types. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
As a key molecule in cellular differentiation, retinoic acid might influence FcRn expression in specific developmental contexts. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cellular growth and protein synthesis. An inhibition of mTOR might reduce overall protein synthesis, potentially affecting FcRn expression indirectly. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits the proteasome, preventing the degradation of proteins. By affecting protein turnover, bortezomib might influence the stability of transcription factors or signaling molecules that regulate FcRn expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA inhibits histone deacetylases, leading to increased gene expression by promoting a more open chromatin structure. If genes encoding FcRn or its regulatory elements are epigenetically silenced, TSA might potentially upregulate FcRn expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine can reduce DNA methylation, potentially activating previously silenced genes. If the FcRn gene or its regulatory pathways are affected by DNA methylation, this compound might influence its expression. | ||||||